MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UP-02-0001738
Lepus Pharmaceuticals Private Limited
Lepus Pharmaceuticals Private Limited - pharma in Aligarh, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.77 Lakh
▼ 6% YoY
Net profit · FY 2025
₹3.24 Lakh
Net margin 47.9%
EBITDA · FY 2025
₹3.24 Lakh
EBITDA margin 47.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Lepus Pharmaceuticals Private Limited
Data last updated:
Lepus Pharmaceuticals Private Limited is a private limited company based in Aligarh, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2020PTC137482. Its GSTIN is 09AAECL4072C1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mahendra Pal Singh and Kuldeep Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9 Kuldeep Vihar Colony Near Sahar Delhi Residency, Aligarh, Uttar Pradesh, India – 202001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.77 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.24 Lakh (net margin 47.9%) and EBITDA of ₹3.24 Lakh (EBITDA margin 47.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
Lepus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-02-0001738).
Company details
CIN U24100UP2020PTC137482
Registration Number 137482
Incorporation Date 04 November 2020
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-02-0001738
Recognitions & Rankings of Lepus Pharmaceuticals
Contact details
Lepus Pharmaceuticals Private Limited's registered office is in Aligarh, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address9 Kuldeep Vihar Colony Near Sahar Delhi Residency, Aligarh, Uttar Pradesh, India – 202001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lepus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Lepus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lepus Pharmaceuticals is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Lepus Pharmaceuticals Private Limited, buy the company report.
Financials of Lepus Pharmaceuticals Private Limited
FY 2025 filings availableLepus Pharmaceuticals Private Limited reported revenue of ₹6.77 Lakh (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹6.77 Lakh ▼ 6%
Net profit · FY 2025
₹3.24 Lakh margin 47.9%
EBITDA · FY 2025
₹3.24 Lakh margin 47.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 927%
3 years · compounded
▲ 207%
Revenue fell 6% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA rose 927% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.9% | ||||
| Net Profit Margin | 47.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lepus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lepus Pharmaceuticals Private Limited
Lepus Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Yadav | Additional Director | 07 Jan 2021 | 5 Years 9 Months | Current |
| Mahendra Pal Singh | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Kuldeep Kumar | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Lepus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lepus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lepus Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Lepus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECL4072C1ZP | Uttar Pradesh | Active | 08 Dec 2020 |
To see the full GST registrations and return filing status of Lepus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lepus Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Rekha Yadav was appointed as Additional Director on 07 Jan 2021.
AGM
Lepus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lepus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Appointed
Rekha Yadav was appointed as Additional Director.
Appointed
Kuldeep Kumar was appointed as Director.
Appointed
Mahendra Pal Singh was appointed as Director.
Incorporation
04 Nov 2020
Lepus Pharmaceuticals Private Limited was registered on 04 Nov 2020 with Roc Uttar Pradesh Ii & aged 5 years 11 months as per MCA records.
Frequently asked questions
Lepus Pharmaceuticals is an active private limited company based in Aligarh, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 November 2020 (6+ years old) and is registered under CIN U24100UP2020PTC137482.
Lepus Pharmaceuticals has 3 current directors:
- Rekha Yadav - Additional Director
- Mahendra Pal Singh - Director
- Kuldeep Kumar - Director
The latest financial statements of Lepus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Lepus Pharmaceuticals is 09AAECL4072C1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Lepus Pharmaceuticals is U24100UP2020PTC137482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lepus Pharmaceuticals was incorporated on 04 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Rekha Yadav was appointed as Additional Director on 07 Jan 2021. Kuldeep Kumar was appointed as Director on 04 Nov 2020. Mahendra Pal Singh was appointed as Director on 04 Nov 2020.
Yes, Lepus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-02-0001738).
The registered office of Lepus Pharmaceuticals is at 9 Kuldeep Vihar Colony Near Sahar Delhi Residency, Aligarh, Uttar Pradesh, India – 202001.
Lepus Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.